Cargando…
Metformin suppresses proliferation and invasion of drug‐resistant breast cancer cells by activation of the Hippo pathway
Drug resistance limits the clinical efficacy of breast cancer therapies, and overexpression or activation of Yes‐associated protein (YAP) is common in drug‐resistant cancer cells. Thus, inhibition of YAP may reduce resistance to anti‐cancer drugs. Metformin (MET), a first‐line diabetes medication th...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7214175/ https://www.ncbi.nlm.nih.gov/pubmed/32281270 http://dx.doi.org/10.1111/jcmm.15241 |
_version_ | 1783531918826930176 |
---|---|
author | Liu, Jie Li, Juan Chen, He Wang, Ruiqi Li, Pingping Miao, Yi Liu, Peijun |
author_facet | Liu, Jie Li, Juan Chen, He Wang, Ruiqi Li, Pingping Miao, Yi Liu, Peijun |
author_sort | Liu, Jie |
collection | PubMed |
description | Drug resistance limits the clinical efficacy of breast cancer therapies, and overexpression or activation of Yes‐associated protein (YAP) is common in drug‐resistant cancer cells. Thus, inhibition of YAP may reduce resistance to anti‐cancer drugs. Metformin (MET), a first‐line diabetes medication that also has anti‐tumour activities, induces AMP‐activated protein kinase (AMPK), directly phosphorylates YAP and inhibits YAP transcriptional activity. In this study, we determined the effect of MET on the proliferation and invasion of drug‐resistant breast cancer cells and then investigated the underlying molecular mechanism. Our in vivo and in vitro experiments indicated that MET suppressed breast cancer by an AMPK‐independent pathway to decrease YAP nuclear localization. In drug‐sensitive cells, MET activated the Hippo pathway by increasing KIBRA and FRMD6 expression, but this did not occur in drug‐resistant cells. Scribble (SCRIB), a cell polarity protein, was notably down‐regulated in tamoxifen‐ and paclitaxel‐resistant breast cancer cells relative to sensitive cells. We also found that MET suppressed the proliferation and invasion of drug‐resistant breast cancer cells by increasing the expression and cell membrane localization of SCRIB, which enhanced the interaction of SCRIB with MST1 and LATS1, and inhibited YAP nuclear localization and transcriptional activity. |
format | Online Article Text |
id | pubmed-7214175 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-72141752020-05-13 Metformin suppresses proliferation and invasion of drug‐resistant breast cancer cells by activation of the Hippo pathway Liu, Jie Li, Juan Chen, He Wang, Ruiqi Li, Pingping Miao, Yi Liu, Peijun J Cell Mol Med Original Articles Drug resistance limits the clinical efficacy of breast cancer therapies, and overexpression or activation of Yes‐associated protein (YAP) is common in drug‐resistant cancer cells. Thus, inhibition of YAP may reduce resistance to anti‐cancer drugs. Metformin (MET), a first‐line diabetes medication that also has anti‐tumour activities, induces AMP‐activated protein kinase (AMPK), directly phosphorylates YAP and inhibits YAP transcriptional activity. In this study, we determined the effect of MET on the proliferation and invasion of drug‐resistant breast cancer cells and then investigated the underlying molecular mechanism. Our in vivo and in vitro experiments indicated that MET suppressed breast cancer by an AMPK‐independent pathway to decrease YAP nuclear localization. In drug‐sensitive cells, MET activated the Hippo pathway by increasing KIBRA and FRMD6 expression, but this did not occur in drug‐resistant cells. Scribble (SCRIB), a cell polarity protein, was notably down‐regulated in tamoxifen‐ and paclitaxel‐resistant breast cancer cells relative to sensitive cells. We also found that MET suppressed the proliferation and invasion of drug‐resistant breast cancer cells by increasing the expression and cell membrane localization of SCRIB, which enhanced the interaction of SCRIB with MST1 and LATS1, and inhibited YAP nuclear localization and transcriptional activity. John Wiley and Sons Inc. 2020-04-12 2020-05 /pmc/articles/PMC7214175/ /pubmed/32281270 http://dx.doi.org/10.1111/jcmm.15241 Text en © 2020 The Authors. Journal of Cellular and Molecular Medicine published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Articles Liu, Jie Li, Juan Chen, He Wang, Ruiqi Li, Pingping Miao, Yi Liu, Peijun Metformin suppresses proliferation and invasion of drug‐resistant breast cancer cells by activation of the Hippo pathway |
title | Metformin suppresses proliferation and invasion of drug‐resistant breast cancer cells by activation of the Hippo pathway |
title_full | Metformin suppresses proliferation and invasion of drug‐resistant breast cancer cells by activation of the Hippo pathway |
title_fullStr | Metformin suppresses proliferation and invasion of drug‐resistant breast cancer cells by activation of the Hippo pathway |
title_full_unstemmed | Metformin suppresses proliferation and invasion of drug‐resistant breast cancer cells by activation of the Hippo pathway |
title_short | Metformin suppresses proliferation and invasion of drug‐resistant breast cancer cells by activation of the Hippo pathway |
title_sort | metformin suppresses proliferation and invasion of drug‐resistant breast cancer cells by activation of the hippo pathway |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7214175/ https://www.ncbi.nlm.nih.gov/pubmed/32281270 http://dx.doi.org/10.1111/jcmm.15241 |
work_keys_str_mv | AT liujie metforminsuppressesproliferationandinvasionofdrugresistantbreastcancercellsbyactivationofthehippopathway AT lijuan metforminsuppressesproliferationandinvasionofdrugresistantbreastcancercellsbyactivationofthehippopathway AT chenhe metforminsuppressesproliferationandinvasionofdrugresistantbreastcancercellsbyactivationofthehippopathway AT wangruiqi metforminsuppressesproliferationandinvasionofdrugresistantbreastcancercellsbyactivationofthehippopathway AT lipingping metforminsuppressesproliferationandinvasionofdrugresistantbreastcancercellsbyactivationofthehippopathway AT miaoyi metforminsuppressesproliferationandinvasionofdrugresistantbreastcancercellsbyactivationofthehippopathway AT liupeijun metforminsuppressesproliferationandinvasionofdrugresistantbreastcancercellsbyactivationofthehippopathway |